Last edition
News about
'COVAXIN': India's first Covid vaccine gets DGCI's approval for clinical trials
Bharat Biotech, has successfully developed Covaxin, India's 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech
FDA Approves New Therapy for Dravet Syndrome
The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures
today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis
China to run human coronavirus vaccine trial in UAE
China National Biotec Group (CNBG) has won approval to run a large-scale Phase 3 clinical trial of its novel coronavirus vaccine candidate in the United Arab Emirates (UAE), the company said. China is seeking to trial potential vaccines overseas because of a lack of new patients at home
Hetero Healthcare set to supply 20,000 vials of generic remdesivir across country
Following the approval of "Covifor", the generic of remdesivir by DCGI, Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each
The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA's Oncology Center of Excellence (OCE). Through a new website, Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials
Patanjali launches ayurvedic medicine Coronil and Swasari to treat COVID-19
Baba Ramdev's Patanjali Yogapeeth based in Haridwar has launched ayurvedic medicine 'Coronil and Swasari', to treat the noval coronavirus infection (COVID-19), which the company said has been shown 100 per cent favourable results during clinical trials on affected patients
Novartis discontinues hydroxychloroquine trial for COVID-19 due to acute enrollment challenges
Novartis has made the decision to stop and discontinue its sponsored hydroxychloroquine(HCQ) clinical trial for COVID-19 due to acute enrollment challenges that have made trial completion infeasible
Cipla launches generic remdesivir for COVID-19
Cipla Limited announced the launch of generic version of remdesivir under its brand name Cipremi. The US FDA issued an emergency use authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients
Glenmark Pharma launches favipiravir drug for COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has launched antiviral drug favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy